We are live on
!
Find out more
Lexicon Pharmaceuticals
LXRX
LXRX
105 hedge funds and large institutions have $1.16B invested in Lexicon Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 41 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
619% more call options, than puts
Call options by funds: $11.5M | Put options by funds: $1.6M
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
95% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 21
45% more capital invested
Capital invested by funds: $802M → $1.16B (+$360M)
12% more funds holding
Funds holding: 94 → 105 (+11)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
105
Holders Change
+11
Holders Change %
+11.7%
% of All Funds
2.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
24
Increased
41
Reduced
21
Closed
12
Calls
$11.5M
Puts
$1.6M
Net Calls
+$9.93M
Net Calls Change
+$9.92M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$21M |
| 2 |
UBS AM
Chicago,
Illinois
|
+$20.9M |
| 3 |
BM
Bridger Management
New York
|
+$11.3M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$10.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.85M |
